(Q40296811)

19 September 2017

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL. (English)

1 reference

19 September 2017

hepatocellular carcinoma

1 reference

1 reference

5

1 reference

19 September 2017

Anita Pathil

1

1 reference

19 September 2017

Sorin Armeanu

2

1 reference

19 September 2017

Sascha Venturelli

3

1 reference

19 September 2017

Paolo Mascagni

4

1 reference

19 September 2017

Michael Gregor

6

1 reference

19 September 2017

Ulrich M Lauer

7

1 reference

19 September 2017

Michael Bitzer

8

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

19 September 2017

1 reference

19 September 2017

43

1 reference

19 September 2017

425-434

1 reference

19 September 2017

3

1 reference

Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin.

19 September 2017

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

7 January 2021

Systemic treatment of hepatocellular carcinoma

1 reference

7 January 2021

Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum

1 reference

7 January 2021

Targeting death receptors in cancer with Apo2L/TRAIL.

1 reference

7 January 2021

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

1 reference

7 January 2021

TRAIL and its receptors as targets for cancer therapy

1 reference

7 January 2021

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

7 January 2021

Clinical development of histone deacetylase inhibitors as anticancer agents

1 reference

7 January 2021

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

1 reference

7 January 2021

The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells

1 reference

7 January 2021

Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells

1 reference

7 January 2021

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate

1 reference

7 January 2021

Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway

1 reference

7 January 2021

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

1 reference

7 January 2021

Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma

1 reference

7 January 2021

Cellular damage to human hepatocytes through repeated application of 5-aminolevulinic acid

1 reference

7 January 2021

Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32).

1 reference

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

7 January 2021

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines

1 reference

7 January 2021

Expression of TNF-related apoptosis-inducing Ligand receptors and antitumor tumor effects of TNF-related apoptosis-inducing Ligand in human hepatocellular carcinoma

1 reference

7 January 2021

Histone deacetylase inhibitors: understanding a new wave of anticancer agents

1 reference

7 January 2021

Histone deacetylase inhibitors and cancer: from cell biology to the clinic

1 reference

7 January 2021

Sensitizing to apoptosis--sharpening the medical sword

1 reference

7 January 2021

Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells

1 reference

7 January 2021

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

1 reference

7 January 2021

Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells

1 reference

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

7 January 2021

The short splice form of Casper/c-FLIP is a major cellular inhibitor of TRAIL-induced apoptosis.

1 reference

7 January 2021

Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis

1 reference

7 January 2021

Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity.

1 reference

7 January 2021

Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells

1 reference

7 January 2021

Identification and functional significance of genes regulated by structurally different histone deacetylase inhibitors

1 reference

7 January 2021

Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers.

1 reference

7 January 2021

High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21054

1 reference

19 September 2017

1 reference